Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogenes, such as that represented by ENSG00000264093, are non-functional, processed or unprocessed genomic sequences derived from the active keratin 18 (KRT18) gene[1][5]. These pseudogenes do not encode functional keratin 18 protein and are dispersed throughout the human genome, especially on chromosomes 12 and 17. The keratin 18 protein itself is a major intermediate filament component of epithelial cells and serves important structural and regulatory functions; however, the pseudogenes are not transcribed into protein and are not currently linked to any direct physiological or disease processes[1][5]. Therefore, keratin 18 pseudogenes are considered non-functional elements in the genome and are not therapeutic targets. Note: - "Keratin 18" (KRT18) is an active, protein-coding gene and is clinically relevant, but its pseudogenes (including those referenced by ENSG00000264093) are not. - If structured data on functional keratin 18 is needed, it should be specifically requested for "keratin 18" or "KRT18."
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene (KRT18P).